Liquid Biopsy Market Size, Industry Analysis Report By Sampling Type (Blood Sampling Liquid Biopsy, Urine Sampling Liquid Biopsy and Saliva), By Circulating Biomarker (Circulating Tumour Cells, Circulating Tumour DNA (CTDNA), Cell-Free DNA, Extracellular Vesicles (EVS)), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By Basis of End Use (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centres) & Region – Forecast

  • 1970-01-01
  • 239
  • Healthcare & Life Sciences
Liquid Biopsy Market: Overview

The global liquid biopsy market size was valued at USD 7.05 billion in 2022 and is expected to grow at a CAGR of 14.4% during the forecast period. By using a blood sample as a non-invasive substitute for surgical biopsies, liquid biopsy enables medical professionals to learn more about a tumor and tailor the treatment accordingly. It can provide a solid foundation for customized therapy and reflect changes in the tumor gene expression profile. It helps with medication resistance, tumor heterogeneity, and early diagnosis screening. In addition, it finds mutations in the EGFR gene, which are found in patients with non-small cell lung cancer (NSCLC).

Liquid Biopsy Market- Growth Factors
Worldwide, there is an increase in cancer patients as a result of sedentary lifestyles and increased cigarette use. One of the main reasons propelling the market is this, along with the rising public awareness of sophisticated minimally invasive (MI) techniques in cancer diagnostics. Additionally, governments in numerous nations are funding research and development (R&D) initiatives to support the launch of cutting-edge cancer treatments. These institutions also make large investments in the growth of the healthcare sector, which presents profitable prospects for industry participants to expand. In addition, major market players are concentrating on product introductions to expand customized medicine globally.

Liquid Biopsy Market – Market Trends
The rising incidence of cancer among the world's population and growing knowledge of the existence of many non-invasive treatments are the main factors driving the global liquid biopsy market.
• Breast cancer is now the most prevalent type of cancer diagnosed worldwide due to the increased prevalence of the disease among females. Around 2.5 million new cases of breast cancer were reported in 2022, with prostate, colorectal, and lung cancers following closely after.
The new liquid biopsy method has a number of advantages, including quick results, low price, early prognosis, eliminating tumor heterogeneity, low risk, and non-invasiveness.
• As a result of early cancer detection, tumour progression monitoring, and clinical prognosis assessment capabilities, liquid biopsy technology is experiencing market expansion.

Liquid Biopsy Market – Segmentation
Liquid Biopsy Market on the basis of Sampling type, the market is fragmented into:
• Blood Sampling Liquid Biopsy
• Urine Sampling Liquid Biopsy and Saliva
• Other Tissue Fluids Sampling Liquid Biopsy

Liquid Biopsy Market on the basis of Products and services, the market is bifurcated into:
• Assays Kits
• Instruments and Services

Liquid Biopsy Market on the basis of circulating biomarker, the market is classified into:
• Circulating Tumour Cells
• Circulating Tumour DNA (CTDNA)
• Cell-Free DNA
• Extracellular Vesicles (EVS)
• Other Circulating Biomarkers

Liquid Biopsy Market on the basis of clinical application, the market is categorized into:
• Early Cancer Screening
• Therapy Selection
• Treatment Monitoring
• Recurrence Monitoring

Liquid Biopsy Market on the basis of end user, the market is segregated into:
• Reference Laboratories
• Hospitals and Physician Laboratories
• Academic and Research Centres
• Other End Users

Liquid Biopsy Market –Regional Analysis
The solid system of healthcare facilities, growing investment from major players in the development of advanced devices, an increasing number of processes for drug development, the strict regulatory environment in the pharmaceutical industry, and the increasing number of research activities in this region all contribute to North America's dominance of the liquid biopsy market. Due to the rise in policy measures to raise awareness, an increase in medical tourism, expanding research activities in the region, an increase in cancer cases, and an increase in the demand for high-quality healthcare in the region, Asia-Pacific is predicted to experience significant growth during the forecast period.

Liquid Biopsy Market – Key Market players
The major players in the market are F. Hoffmann-La Roche Ltd. (Switzerland), Myriad Genetics, Inc. (US), QIAGEN (Netherlands), Thermo Fisher Scientific, Inc. (US), Guardant Health, Inc. (US), MDxHealth SA (Belgium), Exact Sciences Corporation (US), Illumina Inc. (US), Sysmex Inostics (US), Bio-Rad Laboratories, Inc. (US), Biocept, Inc. (US), NeoGenomics, Inc. (US), ANGLE plc (UK), Menarini-Silicon Biosystems (Italy), Vortex Biosciences, Inc. (US), Exosome Diagnostics, Inc. (US), Agena Bioscience, Inc. (US), MedGenome Inc. (US), Epigenomics AG (Germany), and Personal Genome Diagnostics, Inc. (US) among others.

Report scope
Global Liquid Biopsy Market: Historical Years- 2018-2021
Global Liquid Biopsy Market: Forecast Years- 2022-2030
Global Liquid Biopsy Market 2022- USD 7.05 billion
Global Liquid Biopsy Market CAGR- 14.4%

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process

We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).


The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.

Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.


Select a license type that suits your business needs

Single User Access

US $4750

Only Four Thousand Seven Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $5750

Only Five Thousand Seven Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $7750

Only Seven Thousand Seven Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI